WFI
West Family Investments Portfolio holdings
AUM
$383M
1-Year Return
26.07%
This Quarter Return
+1.28%
1 Year Return
+26.07%
3 Year Return
+62.16%
5 Year Return
+133.6%
10 Year Return
+115.07%
AUM
$287M
AUM Growth
-$6.75M
(-2.3%)
Cap. Flow
-$1.65M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
318
New
25
Increased
63
Reduced
174
Closed
34
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.91M |
| 2 |
Schwab US TIPS ETF
SCHP
|
$841K |
| 3 |
Boeing
BA
|
$416K |
| 4 |
Palantir
PLTR
|
$376K |
| 5 |
AT&T
T
|
$357K |
Top Sells
| 1 |
Pfizer
PFE
|
$469K |
| 2 |
Elevance Health
ELV
|
$428K |
| 3 |
KLA
KLAC
|
$402K |
| 4 |
Microsoft
MSFT
|
$364K |
| 5 |
Nike
NKE
|
$342K |
Sector Composition
| 1 | Technology | 22.68% |
| 2 | Financials | 10.32% |
| 3 | Healthcare | 9.68% |
| 4 | Communication Services | 6.71% |
| 5 | Consumer Discretionary | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Home Depot
HD
$417B
| $1.08M | 0.37% |
2,764
+77
| +3% | +$30K |
|
52
Vertex Pharmaceuticals
VRTX
$102B
| $1.07M | 0.37% |
2,652
-12
| -0.5% | -$4.83K |
|
53
Verizon
VZ
$187B
| $1.05M | 0.36% |
26,148
-1,536
| -6% | -$61.4K |
|
54
Marsh & McLennan
MMC
$100B
| $1.04M | 0.36% |
4,878
-112
| -2% | -$23.8K |
|
55
McKesson
MCK
$85.5B
| $1.03M | 0.36% |
1,801
+141
| +8% | +$80.4K |
|
56
CVS Health
CVS
$93.6B
| $1.02M | 0.36% |
22,712
-2,280
| -9% | -$102K |
|
57
Coca-Cola
KO
$292B
| $981K | 0.34% |
15,754
+2,076
| +15% | +$129K |
|
58
Novartis
NVS
$251B
| $974K | 0.34% |
10,009
+270
| +3% | +$26.3K |
|
59
Salesforce
CRM
$239B
| $941K | 0.33% |
2,816
-44
| -2% | -$14.7K |
|
60
AstraZeneca
AZN
$253B
| $922K | 0.32% |
14,068
-852
| -6% | -$55.8K |
|
61
Oracle
ORCL
$654B
| $919K | 0.32% |
5,515
-163
| -3% | -$27.2K |
|
62
Bank of America
BAC
$369B
| $908K | 0.32% |
20,667
-298
| -1% | -$13.1K |
|
63
ASML
ASML
$307B
| $899K | 0.31% |
1,297
-8
| -0.6% | -$5.55K |
|
64
ServiceNow
NOW
$190B
| $893K | 0.31% |
842
+179
| +27% | +$190K |
|
65
Gilead Sciences
GILD
$143B
| $890K | 0.31% |
9,639
-165
| -2% | -$15.2K |
|
66
United Microelectronic
UMC
$17.1B
| $889K | 0.31% |
136,983
-4,678
| -3% | -$30.4K |
|
|
67
AT&T
T
$212B
| $864K | 0.3% |
37,961
+15,680
| +70% | +$357K |
|
68
Linde
LIN
$220B
| $844K | 0.29% |
2,015
-32
| -2% | -$13.4K |
|
69
Consolidated Edison
ED
$35.4B
| $822K | 0.29% |
9,213
-125
| -1% | -$11.2K |
|
70
IBM
IBM
$232B
| $818K | 0.28% |
3,719
-44
| -1% | -$9.67K |
|
71
Regeneron Pharmaceuticals
REGN
$60.8B
| $810K | 0.28% |
1,137
-53
| -4% | -$37.8K |
|
72
Progressive
PGR
$143B
| $787K | 0.27% |
3,284
+6
| +0.2% | +$1.44K |
|
73
Southern Company
SO
$101B
| $776K | 0.27% |
9,431
+45
| +0.5% | +$3.7K |
|
74
Cencora
COR
$56.7B
| $771K | 0.27% |
3,433
+53
| +2% | +$11.9K |
|
75
Chubb
CB
$111B
| $765K | 0.27% |
2,769
+6
| +0.2% | +$1.66K |
|